Increasing Access to Maternal & Reproductive Health Supplies Series

When I first entered this line of work, I often heard one thing: the maternal health market is way too small to be sustainable, much less lucrative. Naturally, one can only expect market failure for maternal health drugs and, by extension, a chronic…

Oxytocin is the first-line drug for the prevention and treatment of postpartum hemorrhage (PPH) and is widely available in developing countries. There is a large market for oxytocin and there are many manufacturers of the drug; however there are growing…

Nearly three years ago, I blogged about a systems approach to improving access for a Maternal Health Task Force (MHTF) series on maternal health commodities. It was an exciting year for maternal health. The UN Commission on Life-Saving Commodities for…

The past ten years have witnessed impressive gains in the availability and use of reproductive health supplies like condoms and oral contraceptives that allow men and women to safely and effectively prevent or space pregnancies. As a result of concerted…

By: Katharine McCarthy, Research Coordinator, Population Council; Saumya Ramarao, Senior Associate, Population Council This post is part of the blog series “Increasing access to maternal and reproductive health supplies: Leveraging lessons learned…

The Maternal Health Task Force (MHTF), the Reproductive Health Supplies Coalition (RHSC)/Maternal Health Supplies Caucus (MHS) and Family Care International (FCI) share the goal of increasing awareness of the key role that reliable access to quality…

By: Safia Ahsan, Senior Health Systems Advisor, Ipas This post is part of a blog series on maternal health commodities. To view the entire series, click here. As the deadline for achieving the Millennium Development Goals (MDGs) approaches, there is…

By: Beth Yeager, Principal Technical Advisor, Management Sciences for Health & Chair, Maternal Health Supplies Caucus, Reproductive Health Supplies Coalition This post is part of a blog series on maternal health commodities. To view the entire…

By: Kelley Boldt, PATH This post is part of a blog series on maternal health commodities. To view the entire series, click here. Kelley Boldt is a young professional supporting PATH’s advocacy efforts to expand access for maternal health medicines in…

By: Jill Sheffield, Founder and President, Women Deliver This post is part of a blog series on maternal health commodities. To view the entire series, click here. Recently, a new study by the Guttmacher Institute and the United Nations Population Fund…